NYSE: RLXRlx Technology Inc Stock
$1.71+0.03 (+1.79%)
Updated Apr 17, 2025
RLX Price
$1.71
Fair Value Price
N/A
Market Cap
$2.69B
52 Week Low
$1.50
52 Week High
$2.69
P/E
28.03x
P/B
1.23x
P/S
7.07x
PEG
0.59x
Dividend Yield
N/A
Revenue
$376.00M
Earnings
$75.59M
Gross Margin
26.4%
Operating Margin
1.09%
Profit Margin
20.1%
Debt to Equity
0.06
Operating Cash Flow
$117M
Beta
1.08
Next Earnings
May 15, 2025
Ex-Dividend
N/A
Next Dividend
N/A
RLX Overview
RLX Technology Inc. manufactures and distributes closed-system rechargeable e-vapor products with various value-added featurese-vapor products in China. RLX Technology was founded in 2018 and is based in Beijing, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RLX's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Tobacco
Industry Rating
D
RLX
Ranked#7 of 8
Ranked#7 of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $42.37 | C | |
| $51.66 | C | |
| $163.21 | C |
Be the first to know about important RLX news, forecast changes, insider trades & much more!
RLX News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RLX ($1.71) is trading above its intrinsic value of $1.33, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RLX is poor value based on its earnings relative to its share price (28.03x), compared to the US market average (27.98x)
P/E vs Market Valuation
RLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RLX due diligence checks available for Premium users.
Valuation
RLX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.03x
Industry
27.52x
Market
27.98x
RLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RLX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
RLX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.23x
Industry
9.03x
RLX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RLX price to earnings growth (PEG)
For valuing profitable companies with growth potential
RLX is good value based... subscribe to Premium to read more.
PEG Value Valuation
RLX's financial health
Profit margin
Revenue
$111.4M
Net Income
$16.7M
Profit Margin
15%
RLX's Earnings (EBIT) of $4.09M... subscribe to Premium to read more.
Interest Coverage Financials
RLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.3B
Liabilities
$120.7M
Debt to equity
0.06
RLX's short-term assets ($1.27B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RLX's short-term assets ($1.27B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RLX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$68.1M
Investing
$260.4M
Financing
-$17.9M
RLX's operating cash flow ($116.87M)... subscribe to Premium to read more.
Debt Coverage Financials
RLX vs Tobacco Stocks
Rlx Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.